Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort

We have retrospectively reviewed toxicities and response of a cohort of primary central nervous system lymphoma (PCNSL) patients treated with high dose parenteral methotrexate (MTX) monotherapy without whole brain radiation. From The Massachusetts General Hospital (MGH) Cancer Registry, active since...

Descripción completa

Detalles Bibliográficos
Autores principales: Cobert, Julien, Hochberg, Ephraim, Woldenberg, Nina, Hochberg, Fred
Formato: Texto
Lenguaje:English
Publicado: Springer US 2009
Materias:
Clinical Study - Patient Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883931/
https://www.ncbi.nlm.nih.gov/pubmed/20020180
http://dx.doi.org/10.1007/s11060-009-0090-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883931/
https://www.ncbi.nlm.nih.gov/pubmed/20020180
http://dx.doi.org/10.1007/s11060-009-0090-3

Ejemplares similares